Cronos (CRON) Cash from Financing Activities (2019 - 2026)

Cronos (CRON) recorded quarterly Cash from Financing Activities of -$18.3 million in Q1 2026, down 146.1% quarter-over-quarter from -$7.4 million in Q4 2025, and down 523.48% on a YoY basis from $4.3 million in Q1 2025.

Cronos (CRON) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Cronos' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at -$18.3 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 523.48% year-over-year to -$18.3 million; the TTM figure through Mar 2026 stood at -$35.2 million (down 902.36% YoY), while the FY2025 annual figure was -$19.9 million, down 1516.98% from the prior year.
  • Cash from Financing Activities was -$18.3 million for Q1 2026 at Cronos, down from -$7.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$13000.0 in Q3 2024 to a low of -$18.3 million in Q1 2026.
  • Historically, Cash from Financing Activities has averaged -$2.5 million across 5 years, with a median of -$620000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 97.52% in 2023, then plunged 14253.85% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$620000.0 in 2022, then soared by 64.84% to -$218000.0 in 2023, then plunged by 43.58% to -$313000.0 in 2024, then tumbled by 2271.57% to -$7.4 million in 2025, then sank by 146.1% to -$18.3 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$18.3 million (Q1 2026), -$7.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Cronos 1.06 Bn 292.44 Mn 19.15 Mn -18.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.27 Mn
Mar 31, 2026 -18.27 Mn
Dec 31, 2025 -7.42 Mn
Dec 31, 2025 -7.42 Mn
Sep 30, 2025 -1.87 Mn
Sep 30, 2025 -1.87 Mn
Jun 30, 2025 -7.69 Mn
Jun 30, 2025 -7.69 Mn
Mar 31, 2025 -2.93 Mn
Mar 31, 2025 -2.93 Mn
Dec 31, 2024 -313,000.00
Dec 31, 2024 -313,000.00
Sep 30, 2024 -13,000.00
Sep 30, 2024 -13,000.00
Jun 30, 2024 -260,000.00
Jun 30, 2024 -260,000.00
Mar 31, 2024 -645,000.00
Mar 31, 2024 -645,000.00
Dec 31, 2023 -218,000.00
Dec 31, 2023 -218,000.00